Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.51 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | SOD1 | P00441 | 1/20 | 0.50 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.49 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.49 |
| ▸ | RXRA | P19793 | 1/20 | 0.47 |
| ▸ | RXRB | P28702 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.45 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8539823 | 0.84 | LTA4H (0.57) | LTA4HBACE1SOD1MRGPRX4GGPS1 | |
| SCHEMBL14280100 | 0.83 | LTA4H (0.54) | LTA4HBACE1SOD1MRGPRX4GGPS1 | |
| SCHEMBL8539801 | 0.82 | LTA4H (0.55) | LTA4HBACE1SOD1MRGPRX4HRH3 | |
| SCHEMBL8537486 | 0.81 | HRH3 (0.56) | LTA4HBACE1SOD1MRGPRX4HRH3 | |
| SCHEMBL452743 | 0.80 | LSS (0.50) | LTA4HHRH3HDAC1HDAC2FFAR1 | |
| SCHEMBL933 | 0.79 | — | — | |
| SCHEMBL30338775 | 0.79 | RXRA (0.70) | LTA4HBACE1SOD1RXRARXRB | |
| SCHEMBL3657427 | 0.79 | LTA4H (0.51) | LTA4HBACE1SOD1MRGPRX4GGPS1 | |
| SCHEMBL2091885 | 0.79 | KDM4E (0.51) | LTA4HMAOB | |
| SCHEMBL1912740 | 0.79 | AGXT (0.53) | LTA4HBACE1SOD1MRGPRX4GGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10611869-B2 | Curable composition and cured product | AGC Inc. (JP) | 2020-04-07 | — | — | US | claimed |
| US-20190218325-A1 | CURABLE COMPOSITION AND CURED PRODUCT | AGC Inc. (JP) | 2019-07-18 | — | — | US | claimed |
| US-20080227885-A1 | Active Energy Beam-Curable Composition for Optical Material | TOAGOSEI CO., LTD. (JP) | 2008-09-18 | — | — | US | claimed |
| EP-3998252-B1 | THIOL COMPOUNDS, SYNTHESIS METHOD THEREFOR, AND UTILIZATION OF SAID THIOL COMPOUNDS | SHIKOKU CHEM (JP) | 2024-04-24 | — | — | EP | disclosed |
| WO-2023218702-A1 | CURING AGENT AND USE THEREOF | 四国化成工業株式会社 | 2023-11-16 | — | — | WO | disclosed |
| WO-2023218862-A1 | THIOL COMPOUND AND USES THEREOF | 四国化成工業株式会社 | 2023-11-16 | — | — | WO | disclosed |
| US-11807596-B2 | Thiol compounds, synthesis method therefor, and utilization of said thiol compounds | SHIKOKU CHEMICALS CORPORATION (JP) | 2023-11-07 | — | — | US | disclosed |
| US-11773207-B2 | Thiol compound, method for synthesizing same, and uses for said thiol compound | SHIKOKU CHEMICALS CORPORATION (JP) | 2023-10-03 | — | — | US | disclosed |
| EP-3617758-B1 | COMPOSITION FOR FORMING OPTICAL WAVEGUIDE WHICH CONTAINS REACTIVE SILSESQUIOXANE COMPOUND | NISSAN CHEMICAL CORP (JP) | 2023-08-09 | — | — | EP | disclosed |
| US-20230210728-A1 | ENERGY RAY-CURABLE COATING MATERIAL FOR THREE-DIMENSIONAL SHAPED ARTICLES, ENERGY RAY-CURABLE MATERIAL KIT FOR THREE-DIMENSIONAL SHAPING INCLUDING SAME, THREE-DIMENSIONAL SHAPED ARTICLE USING SAME, AND METHOD OF PRODUCTION THEREOF | KURARAY NORITAKE DENTAL INC. (JP) | 2023-07-06 | — | — | US | disclosed |
| WO-2023127934-A1 | ENERGY-RAY-CURABLE COMPOSITION FOR THREE-DIMENSIONAL SHAPING USE, DENTAL STRUCTURE, MOUTHPIECE, TEETH-STRAIGHTENING MOUTHPIECE, AND METHOD FOR PRODUCING DENTAL STRUCTURE | クラレノリタケデンタル株式会社 | 2023-07-06 | — | — | WO | disclosed |
| US-20170052446-A1 | PHOTOSENSITIVE RESIN COMPOSITION AND APPLICATION THEREOF | CHI MEI CORPORATION (TW) | 2017-02-23 | — | — | US | disclosed |
| US-20160179004-A1 | PHOTOSENSITIVE POLYSILOXANE COMPOSITION, PROTECTING FILM, AND ELEMENT HAVING PROTECTIVE FILM | CHI MEI CORPORATION (TW) | 2016-06-23 | — | — | US | disclosed |
| EP-2415794-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | Showa Denko K.K. (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-7754781-B2 | Active energy beam-curable composition | TOAGOSEI CO., LTD. (JP) | 2010-07-13 | — | — | US | disclosed |
| US-20080227885-A1 | Active Energy Beam-Curable Composition for Optical Material | TOAGOSEI CO., LTD. (JP) | 2008-09-18 | — | — | US | disclosed |
| US-20080194727-A1 | Active Energy Beam-Curable Composition | TOAGOSEI CO., LTD. (JP) | 2008-08-14 | — | — | US | disclosed |
| EP-1857469-A1 | ACTIVE ENERGY RAY-CURABLE COMPOSITION | TOAGOSEI CO., LTD. (JP) | 2007-11-21 | — | — | EP | disclosed |
| US-5719155-A | CARDIOVASCULAR DISORDERS | JAPAN TOBACCO INC. (JP) | 1998-02-17 | — | — | US | disclosed |
| EP-0677519-A1 | CHROMAN DERIVATIVE AND MEDICINAL USE THEREOF | Japan Tobacco Inc. (JP) | 1995-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230210728-A1 | ENERGY RAY-CURABLE COATING MATERIAL FOR THREE-DIMENSIONAL SHAPED ARTICLES, ENERGY RAY-CURABLE MATERIAL KIT FOR THREE-DIMENSIONAL SHAPING INCLUDING SAME, THREE-DIMENSIONAL SHAPED ARTICLE USING SAME, AND METHOD OF PRODUCTION THEREOF | KIT, SETD7, SETDB1 | LTA4H 3724/4885BACE1 3312/4885SOD1 1111/4885 |
| US-11773207-B2 | Thiol compound, method for synthesizing same, and uses for said thiol compound | TST, TMT1A, CTH | LTA4H 69/4885BACE1 4103/4885SOD1 2640/4885 |
| US-11807596-B2 | Thiol compounds, synthesis method therefor, and utilization of said thiol compounds | TMT1A, CTH, SLC7A11 | LTA4H 45/4885BACE1 2484/4885SOD1 890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.